290 related articles for article (PubMed ID: 33633426)
21. Relugolix/Estradiol/Norethisterone Acetate: A Review in Endometriosis-Associated Pain.
Blair HA
Drugs; 2024 Apr; 84(4):449-457. PubMed ID: 38592603
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a novel pain management device, AT-04, for endometriosis-related pain: study protocol for a phase III randomized controlled trial.
Ishikawa H; Yoshino O; Taniguchi F; Harada T; Momoeda M; Osuga Y; Hikake T; Hattori Y; Hanawa M; Inaba Y; Hanaoka H; Koga K
Reprod Health; 2024 Jan; 21(1):12. PubMed ID: 38279180
[TBL] [Abstract][Full Text] [Related]
23. Elagolix, an Oral GnRH Antagonist for Endometriosis-Associated Pain: A Randomized Controlled Study.
Carr B; Giudice L; Dmowski WP; O'Brien C; Jiang P; Burke J; Jimenez R; Hass S; Fuldeore M; Chwalisz K
J Endometr Pelvic Pain Disord; 2013 Jul; 5(3):105-115. PubMed ID: 30320043
[TBL] [Abstract][Full Text] [Related]
24. Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials.
Pokrzywinski RM; Soliman AM; Chen J; Snabes M; Diamond MP; Surrey E; Coyne KS
Fertil Steril; 2019 Sep; 112(3):545-551. PubMed ID: 31227284
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis.
Xin L; Ma Y; Ye M; Chen L; Liu F; Hou Q
Arch Gynecol Obstet; 2023 Oct; 308(4):1047-1056. PubMed ID: 36656435
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA.
Wang ST; Johnson SJ; Mitchell D; Soliman AM; Vora JB; Agarwal SK
J Comp Eff Res; 2019 Apr; 8(5):337-355. PubMed ID: 30724096
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of eliapixant in endometriosis-associated pelvic pain: the randomized, placebo-controlled phase 2b SCHUMANN study.
Parke S; Gude K; Roth K; Messina F
BMC Womens Health; 2024 Jun; 24(1):353. PubMed ID: 38890641
[TBL] [Abstract][Full Text] [Related]
28. Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix.
Agarwal SK; Singh SS; Archer DF; Mai Y; Chwalisz K; Gordon K; Surrey E
J Pain Res; 2021; 14():263-271. PubMed ID: 33564263
[TBL] [Abstract][Full Text] [Related]
29. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2).
Giudice LC; As-Sanie S; Arjona Ferreira JC; Becker CM; Abrao MS; Lessey BA; Brown E; Dynowski K; Wilk K; Li Y; Mathur V; Warsi QA; Wagman RB; Johnson NP
Lancet; 2022 Jun; 399(10343):2267-2279. PubMed ID: 35717987
[TBL] [Abstract][Full Text] [Related]
30. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
Barra F; Scala C; Ferrero S
Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
[TBL] [Abstract][Full Text] [Related]
31. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.
Alessandro P; Luigi N; Felice S; Maria PA; Benedetto MG; Stefano A
Arch Gynecol Obstet; 2017 Apr; 295(4):827-832. PubMed ID: 28255765
[TBL] [Abstract][Full Text] [Related]
32. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
33. Pain of endometriosis: effects of nafarelin and danazol therapy.
Adamson GD; Kwei L; Edgren RA
Int J Fertil Menopausal Stud; 1994; 39(4):215-7. PubMed ID: 7951404
[TBL] [Abstract][Full Text] [Related]
34. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis.
Vercellini P; Viganò P; Somigliana E
Curr Opin Obstet Gynecol; 2005 Aug; 17(4):359-65. PubMed ID: 15976541
[TBL] [Abstract][Full Text] [Related]
35. Medical Management of Endometriosis.
Rafique S; Decherney AH
Clin Obstet Gynecol; 2017 Sep; 60(3):485-496. PubMed ID: 28590310
[TBL] [Abstract][Full Text] [Related]
36. Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study.
Yoshino O; Suzukamo Y; Yoshihara K; Takahashi N
Adv Ther; 2022 Nov; 39(11):5087-5104. PubMed ID: 36053449
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study.
D'Hooghe T; Fukaya T; Osuga Y; Besuyen R; López B; Holtkamp GM; Miyazaki K; Skillern L
Hum Reprod; 2019 May; 34(5):813-823. PubMed ID: 31067329
[TBL] [Abstract][Full Text] [Related]
38. Current and Emerging Therapeutics for the Management of Endometriosis.
Ferrero S; Barra F; Leone Roberti Maggiore U
Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
[TBL] [Abstract][Full Text] [Related]
39. Endometriosis in teenagers.
Sarıdoğan E
Womens Health (Lond); 2015 Aug; 11(5):705-9. PubMed ID: 26315257
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of elagolix in the treatment of endometriosis.
Perricos A; Wenzl R
Expert Opin Pharmacother; 2017 Sep; 18(13):1391-1397. PubMed ID: 28737050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
